If your GLP-1 was prescribed for aesthetic weight loss or general wellness without a documented medical diagnosis, it does not qualify under IRS Publication 502
The SELECT trial (Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity), a phase 3 study involving 17,604 adults with overweight or obesity and pre-existing CVD but no diabetes, revealed that once-weekly subcutaneous semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20% compared with placebo over a mean follow-up of 39.8 months, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke [48]
I'm admitting right now that I've been terrible about it the past, I don't know, six months or so
M., Charra, B., Jean, G., and Laurent, G
Hepatitis C test Blood test Take a small blood sample from a finger prick - we send you everything you'll need Get your results by text within 72 hours of your sample arriving at the lab